
Manager, Portfolio Comms at @IpsenUS | Public Relations @NewhouseSU '20 | previously: @LaVoieGroup @SUPRSSA @HillCommPR
Boston, MA, United States
Joined March 2017
- Tweets994
- Following1.2K
- Followers291
- Likes2.5K
Anna Army retweeted
Join us at Ipsen's first Invitational Golf Tournament on Aug 28! Held at TPC Norton, all proceeds raised from the event will directly benefit BHCHP. Thank you @IpsenUS and see you on the greens soon! bit.ly/3r4b1qc
Anna Army retweeted
Last night we all danced together in the rain for THE ENTIRE 3.5 HOUR SHOW in foxy Foxborough MA!! We’ve had rain shows at Gillette Stadium before but this was a full on deluge that never let up, I just want to thank that iconic crowd!! Love you so much you have no idea 💕🥰🥲
Anna Army retweeted
Tonight we got to dance in the pouring rain with Taylor Swift (again).
We will NEVER forget it.
🥹🫶
Anna Army retweeted
#RareDisease patients share their advice for navigating relationships and finding community.
#Sponsored by @IpsenUS https://teapawt.net/t.co/i9ubraK5Bb
Anna Army retweeted
@IpsenUS continues its top-to-bottom support for Life Science Cares with the addition of Stewart Campbell to our Board of Advisors. We are thrilled to harness Stewart’s commitment to giving back toward our mission to disrupt the cycle of poverty & inequality in our community!
Anna Army retweeted
Join us in thanking our Autoimmune Liver Disease Forum lead sponsor, @IpsenUS! We are so appreciative of their continued commitment to the American Liver Foundation’s mission and support of our successful forum.
We’re live kicking things off at the Simmons Leadership Conference ! Excited to be here. 🌟 #SLCBoston #RenewalandInnovation @IpsenUS
4
227
Join us today in honor of #RareDiseaseDay in partnership with @TheMightySite for an exciting event about the social impact of living with a rare disease: https://teapawt.net/t.co/575PTXdmY5
This quoted post is unavailable.
1
49
Anna Army retweeted
Anna Army retweeted
Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief Medical Officer dlvr.it/Sg0Xx8
Anna Army retweeted
The EMA has validated Outlook Therapeutics' MAA for ONS-5010, an investigational ophthalmic formulation of bevacizumab, for the treatment of #wetAMD. Decision for potential approval is expected from European Commission in early 2024. Read more: ir.outlooktherapeutics.com/n… $OTLK
Anna Army retweeted
An interesting look at the preclinical data we shared at #ASH22 on our P-FVIII-101 in vivo gene therapy program in Hemophilia A, which we are developing in partnership with @TakedaPharma.
Read the full article from @FierceBiotech here: fiercebiotech.com/research/t…
#genetherapy
Anna Army retweeted
Takeda's $3.6 billion deal with Poseida Therapeutics is paying off with promising preclinical data on the companies’ hemophilia A therapy P-FVIII-101.
fiercebiotech.com/research/t…
Incredible journalism - please read this. Kudos to @NicholasFlorko and @statnews.
STAT just published an eight part series I’ve worked on for the last two years. I’ll have more to say in the AM. But for now, ill just say please read it, and that I’m so thankful to the folks who shared their stories, and all my great colleagues here. statnews.com/death-sentence/























